Article Information
History
- September 27, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Marios K. Georgakis, MD, MSc1,2,
- Rainer Malik, PhD1,
- Dipender Gill, MD3,
- Nora Franceschini, MD, MPH4,
- Cathie L. M. Sudlow, DPhil3,5,
- INVENT Consortium, CHARGE Inflammation Working Group and
- Martin Dichgans, MD1,6,7,*
- 1Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany
- 2Graduate School for Systemic Neurosciences (GSN), Ludwig-Maximilians-University LMU, Munich, Germany
- 3Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom
- 4Department of Epidemiology, UNC Gillings Global School of Public Health, Chapel Hill, NC, USA
- 5Institute for Genetics and Molecular Medicine, University of Edinburgh, UK
- 6Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 7German Centre for Neurodegenerative Diseases (DZNE), Munich, Germany
- ↵*Address for correspondence: Martin Dichgans, MD, Institute for Stroke and Dementia Research, University Hospital of Ludwig-Maximilians-University (LMU), Feodor-Lynen-Str. 17, 81377 Munich, Germany, Phone: +49-89-4400-46018, Fax: +49-89-4400-46040, e-mail: martin.dichgans{at}med.uni-muenchen.de
Posted September 27, 2019.
Interleukin-6 signaling effects on ischemic stroke and other cardiovascular outcomes: a Mendelian Randomization study
